Core Curriculum on Tuberculosis, 2000
Treatment of Latent TB Infection (LTBI)
Bass JB. The tuberculin test, preventive therapy, and elimination
of tuberculosis. Am Rev Respir Dis 1990;141:812-813.
Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine
use of isoniazid prophylaxis in patients with a positive Mantoux
skin test. Am Rev Respir Dis 1990:848-853.
Gordin FM, Matts JP, Miller C, et al. A controlled trial of isoniazid
in persons with anergy and human immunodeficiency virus infection
who are at high risk for tuberculosis. N Engl J Med 1997;337:315-320.
Jordan TJ, Lewit EM, Reichman LB. Isoniazid preventive therapy
for tuberculosis: decision analysis considering ethnicity and gender.
Am Rev Respir Dis 1991;144:1357-1360.
Koplan JP, Farer LS. Choice of preventive treatment for isoniazid-resistant
tuberculous infection: use of decision analysis and the Delphi technique.
Miller B. Preventive therapy for tuberculosis. Medical Clinics
of North America 1993;77:1263-1275.
Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with
isoniazid preventive therapy: a 7-year survey from a public health
tuberculosis clinic. JAMA 1999;281:1014-1018.
OíBrien RJ, PerriŽns JH. Preventive therapy for tuberculosis in
HIV infection: the promise and the reality. AIDS 1995;9:665-673.
Passannante MR, Restifo RA, Reichman LB. Preventive therapy for
the patient with both universal indication and contraindication
for isoniazid. Chest 1993;103:825-831.
Snider DE. Pyridoxine supplementation during isoniazid therapy.
Villarino ME, Ridzon R, Weismuller PC, et al. Rifampin preventive
therapy for tuberculosis infection. Experience with 157 adolescents.
Am J Respir Crit Care Med 1997;155:1735-1738.
Tuberculosis Chemotherapy Centre, Madras. The prevention and treatment
of isoniazid toxicity in the therapy of pulmonary tuberculosis.
II. An assessment of the prophylactic effect of pyridoxine in low
dosage. Bull WHO 1963;29:457-481.
Krishnamurthy DV, Selkon JB, Ramachandran K, et al. Effect of pyridoxine
on vitamin B6 concentrations and glutamic-oxaloacetic
transaminase activity in whole blood of tuberculous patients receiving
high-dosage isoniazid. Bull WHO 1967;36:853-870.
Centers for Disease Control and Prevention. Patient Adherence
to Tuberculosis Treatment. Self-Study Modules on Tuberculosis,
No. 9. Atlanta, Ga: Department of Health and Human Services, CDC;
Centers for Disease Control and Prevention. Contact Investigations
for Tuberculosis. Self-Study Modules on Tuberculosis, No. 6.
Atlanta, Ga: Department of Health and Human Services, CDC; October